Staff reports

Articles

Clascoterone cream 1% phase 3 results presented at meeting. 

Favorable Safety, Efficacy Data on Newer Acne Vulgaris Treatment 

Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.

Ranbaxy launches isotretinoin product in U.S.

Low-dose isotretinoin may be effective, with fewer side effects, when used to treat adult acne, results of a clinical trial presented at the annual congress of the European Academy of Dermatology and Venereology suggest.

Low-dose isotretinoin works for adult acne

Lumenis has signed an agreement with Sound Surgical Technologies (SST) that will make Lumenis a distributor of SST’s VASER Shape MC1 System, a noninvasive body-shaping device for aesthetic practitioners.

Lumenis plans to distribute Sound Surgical Technologies' VASER Shape system

Lucid Inc. is operating under a new company name - Caliber Imaging & Diagnostics Inc., or Caliber ID. The new name reflects the company’s commitment to innovating and delivering the highest-caliber identification tools for accurate, rapid diagnosis to assist in the fight against skin cancer and other diseases, according to company reports.

Lucid Inc. changes name to Caliber Imaging & Diagnostics

Ulthera is now registered in Brazil to market and distribute its UltheraSystem, which combines ultrasound imaging with focused ultrasound therapy in a treatment known as Ultherapy.

Ulthera receives clearance to market Ultherapy in Brazil

Valeant Pharmaceuticals has agreed to acquire Medicis Pharmaceutical for $44 per share in cash, in a deal worth approximately $2.6 billion.

Valeant buys Medicis for $2.6 billion

Palomar Medical Technologies has announced the availability of the Palomar Vectus laser for laser hair removal.

Palomar introduces Vectus laser for hair removal

Galderma’s Cetaphil brand is partnering with Camp Wonder, an initiative of the Children’s Skin Disease Foundation, by donating a portion of the proceeds of a special edition moisturizing cream to the camp, as well as granting $100,000 to fund camp activities.

Cetaphil teams with Children's Skin Disease Foundation's Camp Wonder

Allergan has opened a new research and development center in Bridgewater, N.J.